Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 990.00
-27.00 (-2.65%)
Mar 25, 2026, 7:48 AM KST
Enzychem Lifesciences Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 69,002 | 67,751 | 77,378 | 76,039 | 26,638 | 22,975 |
Revenue Growth | -5.10% | -12.44% | 1.76% | 185.46% | 15.94% | -11.01% |
Gross Profit Gross Profit Growth | 3,379 | 3,383 | 4,310 | 4,348 | 2,416 | 286.72 |
Operating Income Operating Income Growth | -18,861 | -18,270 | -16,376 | -14,733 | -14,662 | -20,754 |
Net Income Net Income Growth | -17,997 | -18,132 | -22,107 | -9,326 | -24,934 | -26,923 |
Earnings Per Share EPS Growth | -227.34 | -234.50 | -270.00 | -110.00 | -316.34 | -533.20 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Health Functional Food Division Health Functional Food Division Growth | 505.23 | 563.06 | 2,006 | 930.87 | 1,007 | 1,371 |
Active Pharmaceutical Ingredients (API) Division Active Pharmaceutical Ingredients (API) Division Growth | 16,091 | 22,341 | 32,166 | 34,181 | 25,630 | 21,604 |
Bio-oil Division Bio-oil Division Growth | 48,426 | 44,846 | 43,206 | 40,927 | - | - |
Total Total Growth | 69,002 | 67,751 | 77,378 | 76,039 | 26,638 | 22,975 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 93,874 | 92,821 | 117,075 | 137,350 | 192,856 | 94,587 |
Total Debt Total Debt Growth | 11,778 | 4,839 | 4,880 | 5,657 | 37,779 | 51,977 |
Net Cash (Debt) Net Cash Growth | 82,096 | 87,982 | 112,195 | 131,693 | 155,077 | 42,609 |
Net Cash Growth | -24.09% | -21.58% | -14.81% | -15.08% | 263.95% | -10.18% |
Net Cash Per Share Net Cash Per Share Growth | 1036.89 | 1137.89 | 1368.88 | 1550.62 | 1967.48 | 843.86 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -19,207 | -11,012 | -573.93 | -10,258 | -14,320 | -18,589 |
Capital Expenditures CapEx Growth | -551.18 | -762.68 | -323.82 | -2,248 | -7,957 | -5,818 |
Free Cash Flow Free Cash Flow Growth | -19,758 | -11,775 | -897.74 | -12,506 | -22,277 | -24,407 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 4.90% | 4.99% | 5.57% | 5.72% | 9.07% | 1.25% |
Operating Margin | -27.33% | -26.97% | -21.16% | -19.38% | -55.04% | -90.33% |
Pretax Margin | -26.03% | -26.92% | -28.54% | -12.99% | -96.03% | -128.42% |
Profit Margin | -26.08% | -26.76% | -28.57% | -12.26% | -93.60% | -117.18% |
FCF Margin | -28.63% | -17.38% | -1.16% | -16.45% | -83.63% | -106.23% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 1.11 | 1.75 | 1.47 | 2.03 | 5.24 | 19.91 |